SAN DIEGO, March 9, 2023 /PRNewswire/ -- Neurocrine Biosciences, Inc. (NBIX) (Nasdaq: NBIX) announced today that new data from RE-KINECT ™, the largest real-world, observational, multicenter study of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results